INSERM 1149, Centre de recherche pour l’inflammation (CRI), Paris-Cité University, Paris, France|||Pathology Department, Bichat Hospital, APHP, Paris-Cité University, Paris, France|||Université Paris-Saclay, Inserm U996, Inflammation, Microbiome and Immun
Antoine Beclere Hospital, Paris, France|||Université Paris-Saclay, Inserm U996, Inflammation, Microbiome and Immunosurveillance, Orsay, France|||Systems Immunology Department, Weizmann Institute of Science, Rehovot, Israel
Université Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, France
Pathology Department, Bichat Hospital, APHP, Paris-Cité University, Paris, France|||INSERM 1149, Centre de recherche pour l’inflammation (CRI), Paris-Cité University, Paris, France
Antoine Beclere Hospital, Paris, France|||Université Paris-Saclay, Inserm U996, Inflammation, Microbiome and Immunosurveillance, Orsay, France
Université Paris-Saclay, Inserm U996, Inflammation, Microbiome and Immunosurveillance, Orsay, France
Pathology Department, Bichat Hospital, APHP, Paris-Cité University, Paris, France
Antoine Beclere Hospital, Paris, France|||Université Paris-Saclay, Inserm U996, Inflammation, Microbiome and Immunosurveillance, Orsay, France|||Paris Center for Microbiome Medicine (PaCeMM) FHU, Paris, France
Université Paris-Saclay, Inserm U996, Inflammation, Microbiome and Immunosurveillance, Orsay, France|||Paris Center for Microbiome Medicine (PaCeMM) FHU, Paris, France
INSERM 1149, Centre de recherche pour l’inflammation (CRI), Paris-Cité University, Paris, France|||Hopital Beaujon, Clichy, France